Product Information
- Product Type
- Recombinant Protein
- Expression System
- E.coli
- Domain
- 61-140aa
- UniProt No.
- P37840
- NCBI Accession No.
- NP_000336.1
- Alternative names
- SNCA, NACP, PARK1, PARK4, PD1, α-synuclein Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor, Parkinson disease 4, autosomal dominant Lewy body
Product Specification
- Molecular Weight
- 8.4 kDa (81aa) confirmed by MALDI-TOF (Molecular weight on SDS-PAGE will appear higher)
- Concentration
- 1mg/ml (determined by BCA assay)
- Formulation
- Liquid in. 20mM Tris-HCl buffer (pH 7.5) containing 0.1M NaCl
- Purity
- > 95% by SDS-PAGE
- Tag
- Non-Tagged
- Applications
- SDS-PAGE
- Storage
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
Data
SDS-PAGE
3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain.
Related Publications
-
Kim EJ, et al. Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation. (J Biol Chem. 2006)
Park JY, et al. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinsons disease. (Glia. 2008)
Fantini J, et al. The fusogenic tilted peptide (67-78) of α-synuclein is a cholesterol binding domain. (Biochim Biophys Acta. 2011)
Kawakami F, et al. Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3β. (FEBS J. 2011)
Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.